CX3CR1

CX3CR1 (C-X3-C motif chemokine receptor 1), also known as fractalkine receptor, is a G protein-coupled receptor that exclusively binds CX3CL1 (fractalkine), a transmembrane chemokine. This receptor-ligand pair mediates leukocyte adhesion, migration, and cell-cell communication through activation of PI3K/Akt, MAPK, and NF-κB pathways. CX3CR1 is highly expressed in monocytes, microglia, and natural killer cells, playing critical roles in neuroimmune interactions, inflammatory responses, and immune surveillance. Its unique ability to sustain both soluble and membrane-bound ligand interactions enables dual signaling modes: chemoattraction and cellular adhesion.
Dysregulation of CX3CR1 signaling is implicated in neurodegenerative disorders (Alzheimer's disease, multiple sclerosis), cardiovascular diseases (atherosclerosis), and cancer metastasis. In Alzheimer's pathology, microglial CX3CR1 modulates amyloid-β clearance and neuroinflammation. Pharmaceutical targeting focuses on allosteric modulators and neutralizing antibodies to disrupt CX3CL1-CX3CR1 axis. Phase I/II trials evaluate antagonists like KAND567 in inflammatory lung diseases, while genetic studies explore its potential as a biomarker for therapeutic stratification in autoimmune conditions. Recent advances include structure-guided drug design leveraging cryo-EM-derived receptor conformations.